ArticleTranslational oncology2022

A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells.

Yumei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.